Functional integrity of T, B, and natural killer cells in homosexual subjects with prodromata and in patients with AIDS. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Functional integrity of T, B, and natural killer cells in homosexual subjects with prodromata and in patients with AIDS.

Ann N Y Acad Sci. 1984;437:28-38. Unique Identifier : AIDSLINE MED/85197362
Bekesi JG; Tsang P; Lew F; Roboz JP; Teirstein A; Selikoff IJ


Abstract: We have examined the numbers of the total T (T11+) cells, T-helper (T4+) cells, T-suppressor (T8+) cells, NK cells (Leu7+), and the functional integrity of T, B, and NK cells in healthy male heterosexuals and compared the data to those obtained from AIDS patients and male homosexuals at risk. The absolute number of total T (T11+) and T-helper (T4+) cell populations were significantly reduced among most of the asymptomatic homosexual males and even more decreased in the AIDS patients. By contrast, the absolute numbers of T-suppressor cells (T8) remained virtually unaltered in the three study populations. The absolute numbers of circulating natural killer cells were similar in the controls and the homosexual subjects, but significantly reduced in the AIDS patients. Proliferative responses to T-cell mitogen (PHA) and T-cell dependent B-cell mitogen (PWM) were severely impaired in prodromal subjects and more so in the AIDS group. Response to PWM was unrelated to the total number of T-suppressor cells, but was associated with a significant decrease in T-helper cell number. Furthermore, all AIDS patients exhibited a significantly depressed NK-cell activity that could not be normalized by addition of alpha IFN or IL-2 and in most cases correlated with the reduced absolute number of NK (Leu7+) cells as well as T-helper cells (T4) and T4/T8 ratios. Three distinctive subgroups with normal (N-NK), significantly heightened (H-NK), and markedly lowered (L-NK) NK activity could be readily identified among the homosexual male population at risk. The N-NK and L-NK groups displayed marginal to no response to in vitro treatment with alpha IFN and interleukin-2. The NK-cell activity, however, in the H-NK group was moderately to strongly inhibited by inclusion of the two immunomodifiers.
Keywords: Acquired Immunodeficiency Syndrome/BLOOD/DIAGNOSIS/*IMMUNOLOGY Adult Antigens, Surface/IMMUNOLOGY Comparative Study Cytotoxicity, Immunologic *Homosexuality Human Immunosuppression Interleukin-2/IMMUNOLOGY Killer Cells, Natural/*IMMUNOLOGY Leukocyte Count Lymphocyte Transformation Male Phytohemagglutinins/IMMUNOLOGY Risk Support, Non-U.S. Gov't T-Lymphocytes/*IMMUNOLOGY JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/blood/diagnosis/KWDimmunologyadultantigens,surface/immunologycomparativestudycytotoxicity,immunologicKWDhomosexualityhumanimmunosuppressioninterleukin-2/immunologykillercells,natural/KWDimmunologyleukocytecountlymphocytetransformationmalephytohemagglutinins/immunologyrisksupport,non-uKWDsKWDgov'tt-lymphocytes/KWDimmunologyjournalarticle
850830
M8580147


Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .